Research in Pomezia
Science Explorer records 4 research institutions in Pomezia, Italy. The largest by output are Sigma Tau (Italy), IRBM Science Park and Procter & Gamble (Italy).
- Research institutions
- 4
- Research works
- 923 ▼ 16% vs 2013–17
- Top-10% rate, 2022–2025
- 14.6% record average 16.5%
A city carries no overall standing here. The composite score is built for institutions and countries, the units its floors and field normalisation were designed around. An empty rank on this page is a statement about the measure, not about the place.
Which research institutions are in Pomezia?
| # | Institution | Works | Against the largest here | World rank |
|---|---|---|---|---|
| 1 | Sigma Tau (Italy)Company | 521 | #16,017 all time | |
| 2 | IRBM Science ParkCompany | 302 | #15,520 all time | |
| 3 | Procter & Gamble (Italy)Company | 60 | not ranked | |
| 4 | Johnson & Johnson (Italy)Company | 40 | not ranked |
By fractional works over the whole record; world rank on research quality in 2022–2025. Bars are scaled to the largest institution in this city, not to anything off the page.
How concentrated the city is
The same institutions as shares of everything the list accounts for. A city that is one university and a city that is twelve read alike as a table and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which keywords describe research in Pomezia?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cell Signaling, Cancer, Mutation, Anticancer Agents, Reactive Oxygen Species, Heart Failure, Protein Tyrosine Phosphatases and PTPN11.
- Monoclonal Antibodies
- Stroke Prevention
- Radiofrequency Ablation
- Anticoagulant Therapy
- Prognostic Factors
- Fibrosis
- Atrial Fibrillation
- Echocardiography
- Minimal Residual Disease
- Sudden Cardiac Death
- Medicinal Chemistry
- Quinones
- Arrhythmias
- Pharmacology
- Antimicrobial Activity
- Protein Tyrosine Phosphatases
- Heart Failure
- Inflammation
- Mutation
- Epidemiology
- Cancer
- Cell Signaling
- Anticancer Agents
- Reactive Oxygen Species
- PTPN11
- Catheter Ablation
- Apoptosis
- Toxicology
- Cytotoxicity
- Cancer Therapy
- Mitochondrial Dysfunction
- Guidelines
- Cardiomyopathy
- Protein Aggregation
- Autoimmunity
- Heterocyclic Compounds
- Angiogenesis
- Drug Discovery
- Risk Stratification
- Ventricular Tachycardia
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this city's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer5▲ 6.2×15 topics
- Epidemiology5▲ 2.0×18 topics
- Cell Signaling4▲ 50×4 topics
- Mutation4▲ 32×4 topics
- Anticancer Agents3▲ 36×4 topics
- Inflammation3▲ 2.4×18 topics
- Reactive Oxygen Species3▲ 12×3 topics
- Heart Failure2▲ 10×4 topics
- PTPN112▲ 499×1 topic
- Protein Tyrosine Phosphatases2▲ 499×1 topic
- Catheter Ablation2▲ 34×2 topics
- Antimicrobial Activity2▲ 23×2 topics
- Apoptosis2▲ 13×6 topics
- Pharmacology2▲ 14×2 topics
- Toxicology2▲ 19×2 topics
- Arrhythmias2▲ 34×2 topics
- Cytotoxicity2▲ 23×1 topic
- Quinones2▲ 215×1 topic
- Cancer Therapy2▲ 5.3×11 topics
- Medicinal Chemistry2▲ 11×5 topics
- Mitochondrial Dysfunction2▲ 9.9×4 topics
- Sudden Cardiac Death2▲ 35×2 topics
- Guidelines2▲ 5.9×3 topics
- Minimal Residual Disease2▲ 39×2 topics
- Cardiomyopathy2▲ 30×2 topics
- Echocardiography1▲ 9.2×2 topics
- Protein Aggregation1▲ 46×2 topics
- Atrial Fibrillation1▲ 22×2 topics
- Autoimmunity1▲ 16×2 topics
- Fibrosis1▲ 12×3 topics
- Heterocyclic Compounds1▲ 25×2 topics
- Prognostic Factors1▲ 5.2×7 topics
- Angiogenesis1▲ 6.5×5 topics
- Anticoagulant Therapy1▲ 17×1 topic
- Drug Discovery1▲ 9.2×3 topics
- Radiofrequency Ablation1▲ 20×1 topic
- Risk Stratification1▲ 29×1 topic
- Stroke Prevention1▲ 18×2 topics
- Ventricular Tachycardia1▲ 42×1 topic
- Monoclonal Antibodies1▲ 21×3 topics
What research is done in Pomezia?
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Protein Tyrosine Phosphatases Molecular Biology 2 works
- 2 Bioactive Compounds and Antitumor Agents Toxicology 2 works
- 3 Cardiac Arrhythmias and Treatments Cardiology and Cardiovascular Medicine 1 works
- 4 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 1 works
- 5 Cardiac pacing and defibrillation studies Cardiology and Cardiovascular Medicine 1 works
- 6 Galectins and Cancer Biology Immunology 1 works
- 7 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 1 works
- 8 Synthesis and biological activity Organic Chemistry 1 works
- 9 Chronic Myeloid Leukemia Treatments Hematology 1 works
- 10 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
Research output over time
The same series as a ribbon — one cell per year, darker for more.